SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMED: BEI Medical Systems Co.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Savant who wrote (3)7/18/2001 8:48:44 PM
From: Savant   of 6
 
TETERBORO, N.J.--(BUSINESS WIRE)--July 18, 2001--BEI Medical
Systems Company, Inc. (NASDAQ: BMED), which received U.S. Food and
Drug Administration approval on April 20 to market its proprietary
device, the Hydro ThermAblator(R), or HTA(R), a minimally invasive
system for treating menorrhagia, or dysfunctional uterine bleeding,
announced today the appointment of three new zone managers to manage
the company's network of independent sales representatives.
The three managers will also support the company's marketing
efforts through workshops and seminars at major universities that will
introduce the HTA(R) technology to interested physicians.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News